JPRN-UMIN000008997
Recruiting
Phase 2
Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the esophageal cancer patient - Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the esophageal cancer patient
Osaka University,Graduate School of Medicine, Department of Gastroenterological Surgery0 sites400 target enrollmentSeptember 29, 2012
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Osaka University,Graduate School of Medicine, Department of Gastroenterological Surgery
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Synchronous or metachronous (within 5 years) malignancies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the stomach cancer patientgastric cancerJPRN-UMIN000007925Osaka University Clinical Research Group for Gastroenterological Study1,000
Recruiting
Not Applicable
Search of a new tumor marker and examination of usefulness by multi-institutinal studyBreast cancer, Thyroid cancer, Esophageal cancer, Gastric cancer, Colon cancer, Liver cancer, Biliary cancer, Pancreatic cancerJPRN-UMIN000014530Toho Univerisity300
Completed
Not Applicable
Circulating tumor cells as a diagnostic marker for pancreatico-biliary malignanciesPancreatico-biliary malignanciesJPRN-UMIN000029808Fukushima Medical University School of Medicine22
Not yet recruiting
Phase 2
A clinical study to assess the Feasibility Study of the Tumour Specific Electroporation (TSE) Technique in Patients with Locally Advanced or Recurrent Head & Neck CancerHealth Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2022/09/045315India Sweden Healthcare Innovation Centre
Recruiting
Not Applicable
Biomarker discovery research for malignant tumors using SCRUM-Japan GI/MONSTAR-SCREEN integrated databaseSolid MalignanciesJPRN-UMIN000049334ational Cancer Center Hospital East27,500